Decibel Cannabis Stock Price, News & Analysis

Decibel Cannabis Company (OTCQB: DBCCF) will report Q4 2025 financial results pre-market on April 16, 2026. A live conference call is scheduled at 10:00 a.m. MDT the same day with Canadian and U.S. dial-ins and conference ID 6569457.

Decibel describes itself as a Canadian branded cannabis manufacturer with consumer brands General Admission, Qwest and Standard Issue and facilities in Calgary, Battleford and Chatham (EU GMP licensed).

Decibel Cannabis Company (OTCQB: DBCCF) entered a conditional agreement to sell its Creston, British Columbia property for approximately $2,500,000 and will consolidate the Creston cultivation facility into its Battleford, Saskatchewan site.

The company said proceeds will repay part of its term debt, the transaction aims to generate $4 million in annual cost savings, is expected to close in April 2026, and is intended to improve production efficiency and strengthen the balance sheet.

Decibel Cannabis Company (OTCQB: DBCCF) granted an aggregate of 11,537,223 stock options effective after market close on February 10, 2026. Each Option is exercisable for one common share at $0.10 per share, the TSXV closing price on February 10, 2026.

The grant is a normal-course, long-term compensation and retention measure. Options vest in three equal annual installments on Jan 1, 2027, 2028 and 2029 and expire on Feb 10, 2031. The company operates cultivation and processing facilities across Canada and sells branded products domestically and beginning international expansion.

Decibel Cannabis (OTCQB: DBCCF) closed a $61 million credit package with ATB Financial, comprising a $40M first lien term, $10M revolver (with $3M available at close) and an $11M second lien term. Maturities were extended to February 2030, and 2026 payment obligations were reduced by $5M. Management said the financing improves free cash flow, removes near-term material maturities, maintains a debt/EBITDA ratio below 2.0x, and supports corporate development and international growth.

Decibel Cannabis Company (OTCQB: DBCCF) reported results of its annual and special meeting held on December 11, 2025. Shareholders approved all items voted on.

Key outcomes: the board size was fixed at four directors and Shawn Dym, Nadia Vattovaz, Jakob Ripshtein, and Benjamin Sze were elected; MNP LLP was appointed auditor; the 2025 Stock Option Plan was reapproved; and shareholders authorized a potential share consolidation up to 50-to-1, although the company said it currently has no intention to effect the consolidation.

Decibel Cannabis (OTCQB: DBCCF) reported Q3 2025 net revenue of $32.9M, up 37% YoY, driven by domestic recreational sales of $24.5M and international sales of $8.4M (AgMedica contribution $7.8M). Gross margin before fair value adjustments was 47% (down from 53% in Q3 2024). Adjusted EBITDA was $7.3M (+40% YoY) and adjusted net income was $3.8M. Free cash flow was $1.5M. Management revised 2025 guidance to ~$115M net revenue and ~$24M Adjusted EBITDA, citing German import permitting delays, a B.C. distribution disruption, and contract fee re‑structuring.

Decibel Cannabis Company (OTCQB: DBCCF) will report its third quarter 2025 financial results pre-market on November 19, 2025. The company will host a live conference call at 10:00 a.m. MST that day; Canadian dial-in is 1-800-715-9871, U.S. dial-in is 1-888-880-3330, conference ID 1629404. Investors can find more information at www.decibelcc.com.

Decibel describes itself as a consumer-focused cannabis company with brands including General Admission, Qwest, and Vox. Following the AgMedica acquisition in Q4 2024, Decibel added an EU-GMP-certified facility and now operates three cultivation facilities plus a processing and manufacturing center to support global distribution.

Decibel Cannabis Company (OTCQB: DBCCF) reported strong Q2 2025 financial results, with net revenue reaching $29.8 million, up 35% year-over-year. The growth was primarily driven by the successful integration of AgMedica, which contributed $5.4 million in total sales.

Key highlights include international sales of $6.1 million, a 176% increase quarter-over-quarter, and net Canadian recreational sales of $23.7 million, up 7% year-over-year. The company achieved an Adjusted EBITDA of $6.3 million, representing a 60% increase, and Free Cash Flow of $2.2 million.

The company's gross margin before fair value adjustments improved to 47% from 42% in Q2 2024, while Adjusted Net Income reached $3.4 million, translating to earnings per share of $0.01.

[ "Net revenue increased by 35% year-over-year to $29.8 million", "International sales grew significantly to $6.1 million, up 176% quarter-over-quarter", "Gross margin improved to 47% from 42% year-over-year", "Adjusted EBITDA increased 60% to $6.3 million", "Free Cash Flow improved by $4.3 million to reach $2.2 million", "Successful integration of AgMedica acquisition contributing $5.4 million in sales" ]

Decibel Cannabis Company (DBCCF) reported its Q1 2025 financial results with net revenue of $21.2 million, up 1.4% year-over-year. The company's international sales surged 527% to $2.2 million, primarily due to contributions from the recently acquired AgMedica. However, net Canadian recreational sales decreased 8% to $19.0 million due to increased competition. The company maintained a gross margin of 50% and reported Adjusted EBITDA of $3.5 million. For full-year 2025, Decibel expects net revenue of $130 million, Adjusted EBITDA of $25 million, and plans to expand its export presence to 9 markets. The company reduced its accounts payable by $2.5 million and debt by $0.8 million, demonstrating commitment to strengthening its balance sheet.